Craniosynostoses: Clinical Trials

2 trials for Craniosynostoses, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Terminated 2
Phase 21Terminated 1

Follow Craniosynostoses: new trials by email Literature Review of Craniosynostoses trials Research Report on Craniosynostoses

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Derazantinib Alone or in Combination With Paclitaxel, Ramucirumab or Atezolizumab in Gastric Adenocarcinoma
Derazantinib, Derazantinib-paclitaxel-ramucirumab combination - Gastric Adenocarcinoma
Phase 1 / Phase 2TerminatedBasilea Pharmaceutica472020-10-062024-04-04
An Open-Label Safety and Tolerability Study of INCB062079 in Subjects With Advanced Hepatocellular Carcinoma and Other Malignancies
INCB062079 - Hepatocellular Carcinoma (HCC), Cholangiocarcinoma
Phase 1TerminatedIncyte Corporation252017-05-252025-10-21

Narrower conditions

Acrocephalosyndactylia (2)  ·  Carcinoma, Hepatocellular (1)  ·  Cholangiocarcinoma (1)  ·  Esophageal Neoplasms (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Ovarian Neoplasms (1)  ·  Stomach Neoplasms (1)

Broader conditions

Bone Diseases (2)  ·  Bone Diseases, Developmental (2)  ·  Congenital Abnormalities (2)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (2)  ·  Craniofacial Abnormalities (2)  ·  Digestive System Diseases (2)  ·  Digestive System Neoplasms (2)  ·  Dysostoses (2)  ·  Gastrointestinal Diseases (2)  ·  Gastrointestinal Neoplasms (2)  ·  Limb Deformities, Congenital (2)  ·  Musculoskeletal Abnormalities (2)  ·  Musculoskeletal Diseases (2)  ·  Neoplasms (2)

Interventions

derazantinib (1)

Sponsors

Basilea Pharmaceutica (1)  ·  Incyte Corporation (1)

Countries

Belgium (2)  ·  United States (2)  ·  Argentina (1)  ·  Australia (1)  ·  Brazil (1)  ·  Chile (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Poland (1)  ·  Russia (1)  ·  South Korea (1)  ·  Spain (1)  ·  Turkey (Türkiye) (1)  ·  United Kingdom (1)

Top investigators

Luis F. Vinas, MD (1)

Results publications

PMID 36787089

NIH funding

2017 (1)